- Home
- NIPG vs GNTA Comparison
NIPG vs GNTA Comparison
Compare NIPG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIPG
- GNTA
- Stock Information
- Founded
- NIPG 2014
- GNTA 2014
- Country
- NIPG Sweden
- GNTA Italy
- Employees
- NIPG N/A
- GNTA N/A
- Industry
- NIPG
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NIPG
- GNTA Health Care
- Exchange
- NIPG NYSE
- GNTA Nasdaq
- Market Cap
- NIPG 73.7M
- GNTA 70.8M
- IPO Year
- NIPG 2024
- GNTA 2021
- Fundamental
- Price
- NIPG $1.32
- GNTA $4.50
- Analyst Decision
- NIPG Strong Buy
- GNTA Strong Buy
- Analyst Count
- NIPG 1
- GNTA 1
- Target Price
- NIPG $6.00
- GNTA $25.00
- AVG Volume (30 Days)
- NIPG 112.4K
- GNTA 2.0K
- Earning Date
- NIPG 04-30-2025
- GNTA 01-01-0001
- Dividend Yield
- NIPG N/A
- GNTA N/A
- EPS Growth
- NIPG N/A
- GNTA N/A
- EPS
- NIPG N/A
- GNTA N/A
- Revenue
- NIPG $85,266,306.00
- GNTA N/A
- Revenue This Year
- NIPG $20.82
- GNTA N/A
- Revenue Next Year
- NIPG $29.70
- GNTA N/A
- P/E Ratio
- NIPG N/A
- GNTA N/A
- Revenue Growth
- NIPG 1.91
- GNTA N/A
- 52 Week Low
- NIPG $0.99
- GNTA $2.79
- 52 Week High
- NIPG $17.76
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- NIPG N/A
- GNTA 59.85
- Support Level
- NIPG N/A
- GNTA $4.16
- Resistance Level
- NIPG N/A
- GNTA $4.37
- Average True Range (ATR)
- NIPG 0.00
- GNTA 0.24
- MACD
- NIPG 0.00
- GNTA 0.01
- Stochastic Oscillator
- NIPG 0.00
- GNTA 25.25
About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS
NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand global influence, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.